| Summary: | Sergiu Chirila,1,* Tony Hangan,2,* Leonard Gurgas,1,* Monica Georgiana Costache,2,* Marinela Anisoara Vlad,3,* Bogdan-Florentin Nitu,3,* Sara Melek Bittar,4,* Aurora Craciun,5,* Laura Condur,6,* Geir Bjørklund7,* 1Department of Medical Informatics and Biostatistics, Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania; 2Department of Dermatology, Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania; 3Doctoral School of Medicine, Ovidius University of Constanta, Constanta, Romania; 4Department of Dermatology, County Clinical Emergency Hospital of Constanta, Constanta, Romania; 5Department of Biochemistry, Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania; 6Department of Family Medicine, Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania; 7Council for Nutritional and Environmental Medicine, Mo i Rana, Norway*These authors contributed equally to this workCorrespondence: Tony Hangan, University Alee nr. 1, Department of Dermatology, Faculty of Medicine, Campus B, Ovidius University of Constanta, Constanta, 900470, Romania, Email tony@medcon.roBackground: This study explores patient acceptance of influenza vaccination administered by pharmacists in Romania during the 2023 season, considering it a novel strategy to address gaps in knowledge. Pharmacy-based vaccination deviates from traditional methods, providing high-risk patients with full reimbursement and others with 50% reimbursement, allowing a choice between family doctors and pharmacies for vaccine administration.Material and Method: The survey includes 15 questions covering socio-demographic data, health information, vaccination preferences, and perceptions of pharmacy-based vaccinations.Results: Respondents showed a positive inclination toward pharmacy-based vaccination, with 68% expressing favorable sentiments, but an awareness gap exists, as only 36% were aware of pharmacy-based ...
|
|---|